Global Glycylcyclines Market, By Drug (Tygacil, Other), Application (Intraabdominal Infection, Skin and Structure Infection, Pneumonia, Skin or Soft Tissue Infection, Others), Dosage (Injection, Powder, Others), Route of Administration (Intravenous, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, the glycylcyclines market is anticipated to grow rapidly during the forecast period. According to the United Nations' World Population Ageing Highlight 2020 study, the worldwide geriatric population is forecast to rise from 727 million in 2020 to 1.5 billion by 2050, a nearly two-fold increase, while the share of the geriatric population in 2020 was about 9.3%, and is expected to rise to 16% by 2050. As a result of the ageing population, the burden of infectious diseases is predicted to rise, complementing the market's expansion over the forecast period. All these factors lead to the high demand of glycylcyclines in the healthcare sector.
Data Bridge Market Research analyses that the glycylcyclines? market was valued at USD 203.5 million in 2021 and is expected to reach USD 257.79 million by 2029, registering a CAGR of 3.00% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Glycylcyclines, which are generated from tetracyclines, are a new class of antibiotics. They were created to address the problem of bacterial resistance to tetracyclines. Antibiotics that disrupt bacterial protein synthesis prevent bacteria from reproducing. They have a broad spectrum of activity against both gram-negative and gram-positive bacteria, but they are particularly effective against bacteria that are tetracycline resistant. Antibiotics containing glycylcycline are effective against methicillin-resistant staphylococci, penicillin-resistant Streptococcus pneumoniae, and vancomycin-resistant enterococci.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug (Tygacil, Other), Application (Intraabdominal Infection, Skin and Structure Infection, Pneumonia, Skin or Soft Tissue Infection, Others), Dosage (Injection, Powder, Others), Route of Administration (Intravenous, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Accord Healthcare (US), Amneal Pharmaceuticals LLC. (US), Apotex Inc. (Canada), Fresenius Kabi AG (Germany), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Meitheal Pharmaceuticals (US), AuroMedics Pharma LLC (US), Xellia Pharmaceuticals (US), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Amgen Inc. (US), Novartis AG (Switzerland), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Sanofi (France), Merck & Co., Inc. (US), AbbVie Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (US)
|
|
Market Opportunities
|
|
Glycylcyclines Market Dynamics
Drivers
- Increasing prevalence of infectious diseases
The rising prevalence of infectious diseases is anticipated to influence the glycylcyclines market's growth. Intraabdominal infection, skin and structure infection, pneumonia, skin or soft tissue infection are the various medical ailments which are treated with the use of glycylcyclines.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of glycylcyclines market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the glycylcyclines market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of glycylcyclines market. Sedentary lifestyle of people and rising pollution are the root causes behind the prevalence of various infectious diseases. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the glycylcyclines market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the glycylcyclines market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the drug development and distribution will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the glycylcyclines market. Additionally, side effects of glycylcyclines such as headache, photosensitivity, nausea, kidney diseases, tinnitus and hypersensitivity reactions will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This glycylcyclines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycylcyclines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Glycylcyclines market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Glycylcyclines Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations therefore as consequence of multiple precautionary lockdowns and other limitations imposed by governments all over the world. The glycylcyclines market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the glycylcyclines market's revenue trajectory.
Global Glycylcyclines Market Scope
The glycylcyclines? market is segmented on the basis of drug, application, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug
- Tygacil
- Other
On the basis of drug, the global hepatic drugs market is segmented into tygacil, and other.
Application
- Intraabdominal Infection
- Skin and Structure Infection
- Pneumonia
- Skin or Soft Tissue Infection
- Others
On the basis of application, the global hepatic drugs market is segmented into intraabdominal infection, skin and structure infection, pneumonia, skin or soft tissue infection and others.
Dosage
- Injection
- Powder
- Others
On the basis of dosage, the glycylcyclines market is segmented into injection, powder and others.
Route of Administration
- Intravenous
- Others
The route of administration segment for the glycylcyclines market is segmented into intravenous and others.
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
On the basis of end-users, the glycylcyclines market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
On the basis of distribution channel, the glycylcyclines market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Glycylcyclines Market Regional Analysis/Insights
The Glycylcyclines? market is analysed and market size insights and trends are provided by country, drug, application, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Glycylcyclines market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the glycylcyclines market because of the growing incidences of pneumonia in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.
Asia-Pacific are expected to grow during the forecast period due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Glycylcyclines Market Share Analysis
The Glycylcyclines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycylcyclines market.
Some of the major players operating in the glycylcyclines market are:
- Accord Healthcare (US)
- Amneal Pharmaceuticals LLC. (US)
- Apotex Inc. (Canada)
- Fresenius Kabi AG (Germany)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Meitheal Pharmaceuticals (US)
- AuroMedics Pharma LLC (US)
- Xellia Pharmaceuticals (US)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Amgen Inc. (US)
- Novartis AG (Switzerland)
- Abbott (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Sanofi (France)
- Merck & Co., Inc. (US)
- AbbVie Inc. (US)
- Sun Pharmaceutical Industries Ltd. (India)
- Eli Lilly and Company (US)
SKU-